Prediction of beneficial effect of beta blocker treatment in severe ischaemic cardiomyopathy: assessment of global left ventricular ejection fraction using dobutamine stress cardiovascular magnetic resonance

Heart. 2005 Nov;91(11):1471-2. doi: 10.1136/hrt.2004.051425.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Agonists
  • Adrenergic beta-Antagonists / therapeutic use*
  • Carbazoles / therapeutic use*
  • Carvedilol
  • Dobutamine
  • Feasibility Studies
  • Heart Failure / diagnosis
  • Heart Failure / etiology
  • Humans
  • Magnetic Resonance Angiography / methods
  • Male
  • Middle Aged
  • Myocardial Ischemia / drug therapy*
  • Propanolamines / therapeutic use*
  • Stroke Volume / drug effects
  • Treatment Outcome
  • Ventricular Dysfunction, Left / diagnosis*
  • Ventricular Dysfunction, Left / etiology

Substances

  • Adrenergic beta-Agonists
  • Adrenergic beta-Antagonists
  • Carbazoles
  • Propanolamines
  • Carvedilol
  • Dobutamine